Joseph Monahan is Chief Scientific Officer of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 265,662 shares of ACRS, which is worth approximately $486,161. The most recent transaction as insider was on Apr 18, 2022, when has been sold 30,000 shares (Common Stock) at a price of $16.28 per share, resulting in proceeds of $488,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 266K
54.65% 3M change
42.23% 12M change
Total Value Held $486,161

Joseph Monahan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 18 2022
SELL
Open market or private sale
$488,400 $16.28 p/Share
30,000 Reduced 22.0%
106,386 Common Stock
Mar 10 2022
SELL
Open market or private sale
$426,762 $15.71 p/Share
27,165 Reduced 16.61%
136,386 Common Stock
Mar 02 2022
BUY
Exercise of conversion of derivative security
-
12,500 Added 7.1%
163,551 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
-
63,750 Added 29.68%
151,051 Common Stock
Feb 09 2022
SELL
Open market or private sale
$4,856 $12.68 p/Share
383 Reduced 0.44%
87,301 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
-
1,050 Added 1.18%
87,684 Common Stock
Sep 01 2021
SELL
Payment of exercise price or tax liability
$17,926 $17.22 p/Share
1,041 Reduced 1.19%
86,634 Common Stock
Sep 01 2021
BUY
Exercise of conversion of derivative security
-
2,333 Added 2.59%
87,675 Common Stock
Jun 02 2021
SELL
Open market or private sale
$477,419 $21.91 p/Share
21,790 Reduced 20.34%
85,342 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
-
50,000 Added 31.82%
107,132 Common Stock
JM

Joseph Monahan

Chief Scientific Officer
Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Track Activities on ACRS